Research directory

Clinical trials

Find trials by company, ticker, title or NCT ID.

Filters
Reset
1,647 trials match your filters.
TrialSponsorPhaseStatusPrimary completion
Long-Term Safety & Efficacy of Apitegromab in Patients With SMA Who Completed Previous Trials of ApitegromabNCT05626855Scholar Rock, Inc.Phase 3Active not recruiting2026-11-01Estimated
A Multi-Centre, Randomised, Controlled, Masked Phase 2 Study of the Safety and Efficacy of KIO-101 Ophthalmic Solution, Versus Vehicle Control in the Treatment of Dry Eye Disease in Patients With Autoimmune DiseaseNCT05629364KPRXPhase 2Terminated2024-01-09Actual
Trial to Evaluate the Efficacy and Safety of TP-03, LIBRA StudyNCT05629390LianBio LLCPhase 3Completed2023-09-15Actual
SUNRISE-3: Efficacy and Safety of Bemnifosbuvir in High-Risk Outpatients With COVID-19NCT05629962AVIRPhase 3Completed2024-04-25Actual
A Study of Botensilimab in Participants With Metastatic Pancreatic CancerNCT05630183AGENPhase 2Completed2026-01-05Actual
Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic ArthritisNCT05640245MoonLake Immunotherapeutics AGPhase 2Completed2023-09-05Actual
A Study of Suvecaltamide in Adults With Moderate to Severe Residual Tremor in Parkinson's DiseaseNCT05642442Jazz PharmaceuticalsPhase 2Completed2024-10-23Actual
Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 YearsNCT05643534ArdelyxPhase 3Completed2026-08-20Actual
An Open-Label Study Evaluating Brexanolone in Adults With TinnitusNCT05645432SUPNPhase 2Completed2023-11-21Actual
Safety and Efficacy of FSD201 for the Treatment of Chronic Pain Associated With Idiopathic MCAS (MCAD)NCT05652907Quantum BiopharmaPhase 2Terminated2023-05-24Actual
A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Huntington's DiseaseNCT05655520SUPNPhase 3Terminated2025-01-20Actual
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)NCT05658510BioXcel Therapeutics IncPhase 3Completed2025-08-15Actual
Study to Evaluate the Safety, Tolerability and Efficacy of BF-200 ALA (Ameluz®) in the Field-directed Treatment of Actinic Keratosis (AK) on the Extremities and Neck/Trunk With Photodynamic Therapy (PDT) Using a RhodoLED LampNCT05662202BFRIPhase 3Completed2025-09-03Actual
A Phase 3 Study of Obexelimab in Patients With IgG4-Related DiseaseNCT05662241Zenas BioPharma (USA), LLCPhase 3Active not recruiting2025-11-13Actual
NKTR-255 vs Placebo Following CD19-directed CAR-T Therapy in Patients With Relapsed/Refractory Large B-cell LymphomaNCT05664217NKTRPhase 2, Phase 3Terminated2024-05-22Actual
Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III)NCT05665088BioXcel Therapeutics IncPhase 3Terminated2023-09-11Actual
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic SeizuresNCT05667142XENEPhase 3Recruiting2027-04Estimated
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)NCT05667493IONSPhase 3Enrolling by invitation2029-08Estimated
Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPANCT05667662PULMPhase 2Terminated2024-02-27Actual
Study of SDX in Patients With Idiopathic Hypersomnia (IH)NCT05668754Zevra TherapeuticsPhase 2Completed2024-02-28Actual
Study of TTI-101 in Participants With Idiopathic Pulmonary FibrosisNCT05671835Tvardi Therapeutics, IncorporatedPhase 2Completed2025-08-14Actual
AMX0035 in Adult Patients With Wolfram SyndromeNCT05676034AMLXPhase 2Active not recruiting2024-07-23Actual
Study of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell CarcinomaNCT05678673ExelixisPhase 3Active not recruiting2026-12-15Estimated
A Study to Evaluate the Efficacy and Safety of TNX-1900 in Patients With Chronic MigraineNCT05679908Tonix Pharmaceuticals, Inc.Phase 2Completed2023-10-08Actual
CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG)NCT05681351IONSPhase 3Active not recruiting2027-03Estimated
A Dose-ranging Study to Investigate Efficacy of Buntanetap in Mild to Moderate ADNCT05686044ANVSPhase 2, Phase 3Completed2024-02-13Actual
Study to Evaluate TNX-601 ER Monotherapy Versus Placebo in Patients With Major Depressive Disorder (MDD)NCT05686408Tonix Pharmaceuticals, Inc.Phase 2Completed2023-09-29Actual
AFFINITY DUCHENNE: RGX-202 Gene Therapy in Participants With Duchenne Muscular Dystrophy (DMD)NCT05693142RGNXPhase 2, Phase 3Active not recruiting2026-09Estimated
A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With DermatomyositisNCT05695950LKFTPhase 2Completed2025-10-13Actual
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 MutationNCT05696626LeonaBioPhase 3Recruiting2027-04Estimated

Primary completion marks the end of data collection for the main study measures, not a results publication date.